# Pharmacological mechanisms by which baicalin ameliorates cardiovascular disease

**Authors:** Lujia Si, Yu Lai

PMC · DOI: 10.3389/fphar.2024.1415971 · Frontiers in Pharmacology · 2024-08-09

## TL;DR

This review summarizes how baicalin, a plant compound, helps treat cardiovascular diseases through various mechanisms like reducing inflammation and protecting heart cells.

## Contribution

The paper provides a comprehensive overview of baicalin's mechanisms in cardiovascular disease, including recent insights into ferroptosis and coagulation.

## Key findings

- Baicalin shows therapeutic effects on atherosclerosis, hypertension, and heart failure through anti-inflammatory and antioxidant actions.
- It inhibits endothelial cell apoptosis and suppresses vascular smooth muscle cell proliferation and migration.
- Baicalin modulates coagulation and fibrinolytic systems and prevents myocardial fibrosis.

## Abstract

Baicalin is a flavonoid glycoside obtained from the dried root of Scutellaria baicalensis Georgi, which belongs to the Labiatae family. Accumulating evidence indicates that baicalin has favorable therapeutic effects on cardiovascular diseases. Previous studies have revealed the therapeutic effects of baicalin on atherosclerosis, myocardial ischemia/reperfusion injury, hypertension, and heart failure through anti-inflammatory, antioxidant, and lipid metabolism mechanisms. In recent years, some new ideas related to baicalin in ferroptosis, coagulation and fibrinolytic systems have been proposed, and new progress has been made in understanding the mechanism by which baicalin protects cardiomyocytes. However, many relevant underlying mechanisms remain unexplained, and much experimental data is lacking. Therefore, further research is needed to determine these mechanisms. In this review, we summarize the mechanisms of baicalin, which include its anti-inflammatory and antioxidant effects; inhibition of endothelial cell apoptosis; modulation of innate immunity; suppression of vascular smooth muscle cells proliferation, migration, and contraction; regulation of coagulation and fibrinolytic systems; inhibition of myocardial hypertrophy; prevention of myocardial fibrosis; and anti-apoptotic effects on cardiomyocytes.

## Linked entities

- **Chemicals:** baicalin (PubChem CID 64982)
- **Diseases:** atherosclerosis (MONDO:0005311), heart failure (MONDO:0005252)

## Full-text entities

- **Diseases:** myocardial ischemia/reperfusion injury (MESH:D015427), heart failure (MESH:D006333), myocardial hypertrophy (MESH:D006984), atherosclerosis (MESH:D050197), inflammatory (MESH:D007249), cardiovascular disease (MESH:D002318), hypertension (MESH:D006973), myocardial fibrosis (MESH:D005355)
- **Chemicals:** Baicalin (MESH:C038044), lipid (MESH:D008055), flavonoid glycoside (-)
- **Species:** Scutellaria baicalensis (Baikal skullcap, species) [taxon 65409]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11341428/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11341428/full.md

## References

136 references — full list in the complete paper: https://tomesphere.com/paper/PMC11341428/full.md

---
Source: https://tomesphere.com/paper/PMC11341428